Glyburide Advantage in Malignant Edema and Stroke Pilot
Clinical trial NCT01268683 · COMPLETED
Trial details
- NCT number
- NCT01268683
- Sponsor
- Remedy Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-26
- Primary completion
- 2012-06-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.